Abstract
BackgroundIn the ASSURE trial (NCT00048932) comparing abatacept with placebo for the treatment of RA, there was an increased incidence of respiratory serious adverse events (SAEs; COPD exacerbation/worsening, bronchitis and pneumonia)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have